Top Picks
Richard Aplenc, MD, PhD, MSCE
- e-Newsletter: A Case Study in Secondary AML: Best Practice for Treatment Selection - J. Lancet, MD
- Posted 01/20
- e-Newsletter: Is it possible to deliver liposomal daunorubicin and cytarabine on an outpatient basis? - E. Wang, MD - Posted 12/07
- VIDEO FAQ: What are the key factors you must take into consideration in determining upfront treatment for patients with high-risk, secondary AML? - E. Wang, MD (2:47) - Posted 11/30
- e-Newsletter: Expert Opinions on Common Clinical Challenges in AML - N. Daver, MD; J. Altman, MD; A. Perl, MD - Posted 10/14
- e-Newsletter: Key Updates from ASCO 2020 and EHA 2020: Experts Discuss Data and Implications Important to Clinical Practice - N. Daver, MD; A. Perl, MD - Posted 10/07
- VIDEO FAQ: New Advances in AML Discussion - N. Daver, MD; J. Altman, MD; A. Perl, MD(15:33) - Posted 07/10
- Additional activities...
MediCom Oncology Links
Please visit these other members of the MediCom Oncology family of sites.
